Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)	Series A Convertible Preferred Stock	Common Stock	Additional Paid-in capital	Other comprehensive loss	Accumulated deficit	Total
Equity, beginning balance at Dec. 31, 2019		$ 1,051	$ 226,304,519	$ (11,533,778)	$ (90,528,263)	$ 124,243,530
Equity, beginning balance (in shares) at Dec. 31, 2019		1,051,137
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		$ 8	150,941			150,949
Exercise of stock options (in shares)		8,203
Stock based compensation			4,983,023			4,983,023
Foreign currency translation				1,496,517		1,496,517
Net loss					(53,478,812)	(53,478,812)
Equity, ending balance at Dec. 31, 2020		$ 1,059	231,438,483	(10,037,261)	(144,007,075)	77,395,207
Equity, ending balance (in shares) at Dec. 31, 2020		1,059,340
Temporary equity, ending balance (in shares) at Dec. 31, 2021	0
Increase (Decrease) in Stockholders' Equity
Issuance of common stock pursuant to at-the-market stock sales, net		$ 18	1,538,627			1,538,645
Issuance of common stock pursuant to at-the-market stock sales, net (in shares)		18,338
Exercise of stock options		$ 11	208,356			208,367
Exercise of stock options (in shares)		11,319
Vesting of restricted stock units		$ 4	(4)
Vesting of restricted stock units (in shares)		3,970
Stock based compensation			7,813,743			7,813,743
Foreign currency translation				(321,695)		(321,695)
Net loss					(37,127,303)	(37,127,303)
Equity, ending balance at Dec. 31, 2021		$ 1,092	240,999,206	(10,358,956)	(181,134,378)	49,506,964
Equity, ending balance (in shares) at Dec. 31, 2021		1,092,967
Increase (Decrease) in Temporary Equity
Issuance of preferred stock upon acquisition of Atrin	$ 68,777,468
Issuance of preferred stock upon acquisition of Atrin (in shares)	2,949,630
Conversion of preferred stock into common stock	$ (67,466,405)
Conversion of preferred stock into common stock (in shares)	(2,893,403)
Temporary equity, ending balance (in shares) at Dec. 31, 2022	56,227
Temporary equity, ending balance at Dec. 31, 2022	$ 1,311,063
Increase (Decrease) in Stockholders' Equity
Issuance of common stock pursuant to at-the-market stock sales, net		$ 39	682,934			682,973
Issuance of common stock pursuant to at-the-market stock sales, net (in shares)		38,481
Issuance of stock upon acquisition of Atrin		$ 56	1,329,643			1,329,699
Issuance of stock upon acquisition of Atrin (in shares)		55,869
Value of assumed stock options			2,602,850			2,602,850
Vesting of restricted stock units		$ 21	(21)
Vesting of restricted stock units (in shares)		21,251
Stock based compensation			16,981,266			16,981,266
Foreign currency translation				(264,452)		(264,452)
Conversion of preferred stock into common stock		$ 1,447	67,464,958			67,466,405
Conversion of preferred stock into common stock (in shares)		1,446,701
Net loss					(112,662,027)	(112,662,027)
Equity, ending balance at Dec. 31, 2022		$ 2,655	$ 330,060,836	$ (10,623,408)	$ (293,796,405)	$ 25,643,678
Equity, ending balance (in shares) at Dec. 31, 2022		2,655,269